Drug · DIN 02563363
JAMP RISPERIDONE TABLETS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 31, 2026; first marketed August 31, 2026.
- Drug Identification Number (DIN)
- 02563363
- Company (DIN owner)
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- September 9, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 3 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 2, 2025: NOC 36463Abbreviated New Drug Submission (ANDS)
Other DINs named JAMP RISPERIDONE TABLETS
- DIN 02563320 · Marketed
- DIN 02563339 · Marketed
- DIN 02563347 · Marketed
- DIN 02563355 · Approved
- DIN 02563371 · Approved